First Merchants Corp Outlook Therapeutics, Inc. Transaction History

First Merchants Corp

  • $1.37 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$0.91 - $2.01 $42,224 - $93,263
46,400 Added 45.15%
149,170 $151,000
Q1 2022

Apr 26, 2022
BUY
$1.22 - $2.03 $83,845 - $139,513
68,726 Added 201.87%
102,770 $182,000
Q4 2021

Jan 27, 2022
BUY
$1.27 - $2.23 $43,235 - $75,918
34,044 New
34,044 $46,000

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.18B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track First Merchants Corp Portfolio

Follow First Merchants Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email